MRC — Mercator Medical SA Cashflow Statement
0.000.00%
Last trade - 00:00- PLN535.74m
- PLN414.78m
- PLN574.18m
Annual cashflow statement for Mercator Medical SA, fiscal year end - December 31st, PLN millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | C2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 445 | -191 | -22.8 | 43.4 | 29.3 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | -110 | 106 | -4.94 | -74.5 | -28.1 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 149 | 100 | 5.57 | -58.3 | 7.44 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Payable / Accrued Expenses | |||||
| Net Change in Other Assets & Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 503 | 40.8 | -0.086 | -66 | 37.5 |
| Capital Expenditures | -177 | -110 | -39.1 | -18.7 | -50.9 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -53.3 | -37.1 | 72.7 | 5.85 | 45.5 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -230 | -147 | 33.6 | -12.9 | -5.47 |
| Financing Cash Flow Items | -0.117 | -0.015 | -0.19 | -0.23 | -0.442 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -334 | -1.39 | -41.1 | -16.1 | -14.6 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -60.2 | -116 | -7.37 | -93 | 17.7 |